Stereotactic body radiation therapy for liver and lung oligometastases from colorectal cancer: safety, local efficacy and prognostic factors
10.3760/cma.j.cn113030-20200330-00145
- VernacularTitle:立体定向放疗用于结直肠癌肝与肺寡转移的研究进展
- Author:
Junqin LEI
1
;
Wenyang LIU
;
Jing JIN
Author Information
1. 国家癌症中心/国家肿瘤临床医学研究中心/中国医学科学院北京协和医学院肿瘤医院放疗科 100021
- Keywords:
Neoplasm/oligometastasis;
Colorectal cancer, liver metastasis/stereotactic body radiation therapy;
Colorectal cancer, lung metastasis/Stereotactic body
- From:
Chinese Journal of Radiation Oncology
2021;30(12):1316-1320
- CountryChina
- Language:Chinese
-
Abstract:
Oligometastasis is an intermediate status between the locally advanced and wide spread disease. Patients with oligometastasis may obtain long-term survival after local treatment. Stereotactic body radiation therapy (SBRT) can deliver radical ablative doses in a small number of fractions, which is a highly precise local ablation therapy. Approximately half of patients diagnosed with colorectal cancer (CRC) will develop metastases, with the liver and lung as the most common site of involvement. In this article, the safety, local efficacy and prognostic factors of SBRT for liver and lung oligometastases from CRC were illustrated. The highlights of SBRT implementation were also discussed. SBRT is safe and effective for oligometastases from CRC under respiratory motion management and robust quality assurance.
